Most Recent
ACCC’s Sims wins three-year term extension
People In The News 2018-10-25 11:24 pm By Cat Fredenburgh

ACCC boss Rod Sims has won a five-year extension of his term as Chair, ensuring the high energy regulator will continue to make good on its promises of higher fines and tougher enforcement of the nation’s competition and consumer laws.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Scenic cruise passengers can’t claim damages for disappointment, appeals court says
Appeals 2018-10-25 10:19 pm By Cat Fredenburgh

Scenic Tours has won a major victory on appeal in a class action against a ruling that put it on the hook for claims that luxury European river cruise passengers were owed damages and compensation after they were forced to take the bus because of flood waters.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Aboriginal art supplier misled consumers with Indonesian-made fakes, judge finds
Competition & Consumer Protection 2018-10-24 9:52 pm By Christine Caulfield

A judge has found an Aboriginal art and souvenir supplier misled consumers by creating the false impression its products were made in Australia by Indigenous people, when they were actually made in Indonesia, the consumer watchdog said Wednesday.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AMS loses bid to restrict group size in pelvic mesh class action
Class Actions 2018-10-24 7:36 pm By Cat Fredenburgh

The judge overseeing a class action against American Medical Systems over allegedly defective pelvic mesh implants has rejected the medical device maker’s bid to alter the start date for a sub-group of class members.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Heinz drops appeal in sugary kids snacks case
Appeals 2018-10-24 12:35 pm By Cat Fredenburgh

H.J. Heinz Company has dropped its appeal of a ruling that it marketed its sugary snacks to kids as healthy, after the ACCC won a fraction of the $10 million fine it sought for the consumer law violations.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ACCC to act as intervenor in Nature’s Care case over Australian Made logo
Competition & Consumer Protection 2018-10-23 10:40 pm By Cat Fredenburgh

The Australian Competition and Consumer Commission has successfully escaped a lawsuit by a Chinese vitamin company Nature’s Care after arguing it had been wrongly “dragged” into the case.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bannister Law off Ford class action in wake of funder feud
Class Actions 2018-10-22 3:49 pm By Cat Fredenburgh

Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that’s backing the case.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Cash Converters to pay $16.4M to settle consumer class action
Class Actions 2018-10-22 1:48 pm By Cat Fredenburgh

Cash Converters has reached a settlement on the eve of trial in one of two consumer class actions alleging it engaged in unconscionable conduct by imposing high interest rates on short-term loans.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ASIC defeats referee bid in AMP insurance case
Insurance 2018-10-19 3:27 pm By Miklos Bolza

ASIC has successfully opposed a Federal Court judge’s push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ACCC’s loss in Pfizer misuse of market power case to stand
Competition & Consumer Protection 2018-10-19 2:27 pm By Cat Fredenburgh

The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?